Award

Purchase of Fibroscan standalone liver elastography machine

CHELSEA & WESTMINSTER HOSPITAL NHS FOUNDATION TRUSTS

This public procurement record has 1 release in its history.

Award

16 Jul 2020 at 11:28

Award Notice
Summary of the contracting process

The Chelsea & Westminster Hospital NHS Foundation Trust in London has completed a procurement process for the purchase of a Fibroscan standalone liver elastography machine, valued at £100,000. This procurement was classified under the medical equipment category and is part of the broader healthcare industry. The award notice was published on 16 July 2020, following a tender period that concluded on 16 June 2020. The contract is set to run from 1 July 2020 until 30 June 2025.

This tender presents a significant opportunity for businesses in the medical equipment sector, particularly those specialising in diagnostic imaging or related technologies. Given the growing need for advanced healthcare solutions, especially for conditions like Non-alcoholic fatty liver disease, companies that can offer innovative medical devices, particularly for obese patients, would be well-suited to explore such contracts. The procurement method employed indicates a competitive environment, which may favour established suppliers with proven track records in the healthcare industry.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Purchase of Fibroscan standalone liver elastography machine

Notice Description

The Trust required to purchase new standalone liver elastography machine. The 'Fibroscan' is now the gold standard method to assess the degree of liver fibrosis in patients without the need for a biopsy and is used in clinical practice guidelines (including NICE) for many disorders such as Hepatitis B, Hepatitis C and Non-alcoholic fatty liver disease (NAFLD). In recent years, the number of patients being seen in the liver clinic with NAFLD has increased dramatically. This is most commonly related to being overweight. Patients with NAFLD are not only at risk of developing liver fibrosis but also are at risk of heart attacks, strokes and diabetes. The new Fibroscan machines are able to measure the amount of fat within the liver with the CAP score (controlled attenuation parameter) to diagnose this without the need for biopsy. The standard 'M-probe' that the Fibroscan uses is often unable to take an accurate reading in patients who are very overweight. In these cases, the new 'XL-probe' is required to take the Fibroscan measurements.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-19b43008-2c77-43f8-927e-6e2475d12f17
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/cccf863c-cc1a-4315-a283-5cf37abd93b1
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Not Specified
Procurement Method Details
Other -
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33000000 - Medical equipments, pharmaceuticals and personal care products

Notice Value(s)

Tender Value
£100,000 £100K-£500K
Lots Value
Not specified
Awards Value
£100,000 £100K-£500K
Contracts Value
Not specified

Notice Dates

Publication Date
16 Jul 20205 years ago
Submission Deadline
16 Jun 2020Expired
Future Notice Date
Not specified
Award Date
29 Jun 20205 years ago
Contract Period
30 Jun 2020 - 30 Jun 2025 Over 5 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
CHELSEA & WESTMINSTER HOSPITAL NHS FOUNDATION TRUSTS
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SW10 0XD
Post Town
South West London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI3 Inner London - West
Small Region (ITL 3)
TLI33 Kensington & Chelsea and Hammersmith & Fulham
Delivery Location
Not specified
Local Authority
Hammersmith and Fulham
Electoral Ward
Sands End
Westminster Constituency
Chelsea and Fulham

Supplier Information

Number of Suppliers
1
Supplier Name

ECHOSENS

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-19b43008-2c77-43f8-927e-6e2475d12f17-2020-07-16T12:28:30+01:00",
    "date": "2020-07-16T12:28:30+01:00",
    "ocid": "ocds-b5fd17-19b43008-2c77-43f8-927e-6e2475d12f17",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "CHELWEST-DN480811-85082945",
        "title": "Purchase of Fibroscan standalone liver elastography machine",
        "description": "The Trust required to purchase new standalone liver elastography machine. The 'Fibroscan' is now the gold standard method to assess the degree of liver fibrosis in patients without the need for a biopsy and is used in clinical practice guidelines (including NICE) for many disorders such as Hepatitis B, Hepatitis C and Non-alcoholic fatty liver disease (NAFLD). In recent years, the number of patients being seen in the liver clinic with NAFLD has increased dramatically. This is most commonly related to being overweight. Patients with NAFLD are not only at risk of developing liver fibrosis but also are at risk of heart attacks, strokes and diabetes. The new Fibroscan machines are able to measure the amount of fat within the liver with the CAP score (controlled attenuation parameter) to diagnose this without the need for biopsy. The standard 'M-probe' that the Fibroscan uses is often unable to take an accurate reading in patients who are very overweight. In these cases, the new 'XL-probe' is required to take the Fibroscan measurements.",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "33000000",
            "description": "Medical equipments, pharmaceuticals and personal care products"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 100000,
            "currency": "GBP"
        },
        "procurementMethodDetails": "Other -",
        "tenderPeriod": {
            "endDate": "2020-06-16T23:59:59+01:00"
        },
        "contractPeriod": {
            "startDate": "2020-07-01T00:00:00+01:00",
            "endDate": "2025-06-30T23:59:59+01:00"
        },
        "suitability": {
            "sme": false,
            "vcse": false
        },
        "mainProcurementCategory": "goods"
    },
    "parties": [
        {
            "id": "GB-CFS-147750",
            "name": "Chelsea & Westminster Hospital NHS Foundation Trusts",
            "identifier": {
                "legalName": "Chelsea & Westminster Hospital NHS Foundation Trusts"
            },
            "address": {
                "streetAddress": "Unit G3, Harbour Yard, Chelsea Harbour",
                "locality": "London",
                "postalCode": "SW10 0XD",
                "countryName": "England"
            },
            "contactPoint": {
                "email": "tenders@chelwest.nhs.uk"
            },
            "roles": [
                "buyer"
            ]
        },
        {
            "id": "GB-CFS-147751",
            "name": "Echosens UK Ltd",
            "identifier": {
                "legalName": "Echosens UK Ltd"
            },
            "address": {
                "streetAddress": "4 Burley House Caspian Road Altrincham Cheshire"
            },
            "details": {
                "scale": "large",
                "vcse": false
            },
            "roles": [
                "supplier"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-147750",
        "name": "Chelsea & Westminster Hospital NHS Foundation Trusts"
    },
    "awards": [
        {
            "id": "ocds-b5fd17-19b43008-2c77-43f8-927e-6e2475d12f17-1",
            "status": "active",
            "date": "2020-06-30T00:00:00+01:00",
            "datePublished": "2020-07-16T12:28:30+01:00",
            "value": {
                "amount": 100000,
                "currency": "GBP"
            },
            "suppliers": [
                {
                    "id": "GB-CFS-147751",
                    "name": "Echosens UK Ltd"
                }
            ],
            "contractPeriod": {
                "startDate": "2020-07-01T00:00:00+01:00",
                "endDate": "2025-06-30T23:59:59+01:00"
            },
            "documents": [
                {
                    "id": "1",
                    "documentType": "awardNotice",
                    "description": "Awarded contract notice on Contracts Finder",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/cccf863c-cc1a-4315-a283-5cf37abd93b1",
                    "datePublished": "2020-07-16T12:28:30+01:00",
                    "format": "text/html",
                    "language": "en"
                }
            ]
        }
    ]
}